What to Do When Riluzole Causes Adverse Events in Amyotrophic Lateral Sclerosis
In patients with amyotrophic lateral sclerosis (ALS) receiving riluzole, the emergence of adverse events requires a structured clinical response. This protocol provides guidance for that specific scenario.
A patient with ALS on riluzole develops adverse events during the course of treatment. A protocol-guided response is indicated to manage tolerability while maintaining appropriate care.
The protocol specifies an adjustment to the riluzole regimen as the immediate response to adverse events, with subsequent clinical re-evaluation. The full structured guidance — including the precise steps, reassessment criteria, and decision pathway — is available in the complete protocol.
References
DOI: 10.1111/ene.16264
If adverse events are noted, consider reducing the dose and re-evaluate.
View source ↗